Dashboard
Weak Long Term Fundamental Strength with an average Return on Capital Employed (ROCE) of 7.82%
- Poor long term growth as Operating profit has grown by an annual rate 38.25% of over the last 5 years
- Low ability to service debt as the company has a high Debt to EBITDA ratio of 3.69 times
With a growth in Net Profit of 2822.22%, the company declared Outstanding results in Mar 26
Stock is technically in a Mildly Bullish range
With ROCE of 21.5, it has a Very Attractive valuation with a 2 Enterprise value to Capital Employed
Majority shareholders : Non Institution
Stock DNA
Paper, Forest & Jute Products
INR 35 Cr (Micro Cap)
12.00
31
0.00%
1.07
6.86%
3.15
Total Returns (Price + Dividend) 
Grameva for the last several years.
Risk Adjusted Returns v/s 
Returns Beta
News
Announcements 
Closure of Trading Window
25-Sep-2026 | Source : BSEPersuant to SEBI (Prohibition of Insider Trading) Regulations 2015 the "Trading Window" for dealing in the securities of the Company will remain closed for all Designated Employees and their Immediate Relatives Directors and Promoters from 1st October 2026. The Trading Window will open 48 hours after the announcement of Unaudited Financial Results of the Company for the quarter and half year ending on 30th September 2026 to the Stock Exchanges.
Announcement under Regulation 30 (LODR)-Newspaper Publication
15-Aug-2026 | Source : BSEPursuant to Regulation 30 33 and 47 of SEBI (LODR) Regulations 2015 we are enclosing herewith a copy of the newspaper advertisement published for the Un-audited Financial Results for the quarter and three months ended June 30 2026 in Business Standard (National Daily English) and Arthik Lipi (Kolkata edition in Bengali) on 15th August 2026.
Board Meeting Outcome for Outcome Of The Board Meeting
14-Aug-2026 | Source : BSEThe Board of Directors at its Meeting held on 14.08.2026 approved the Unaudited Financial Results of the Company for the quarter and three months ended 30.06.2026 after review by the Audit Committee. The Unaudited Financial Results along with the Limited Review Report of the Auditors are enclosed pursuant to Regulation 30 read with Schedule III and Regulation 33 of the SEBI (LODR) Regulations 2015 for publication in newspapers and submission to the Stock Exchanges. Further the Board approved enhancement of credit facilities from Rs. 8.00 Crore to Rs. 18.89 Crore vide Sanction Letter No. AXIS-00000241732-CBG/SEG/Shakespeare Sarani 1/2026-27 dated 28.07.2026. The closure of the trading window for the quarter ended 30.06.2026 was duly noted and the reopening date considered accordingly.
Corporate Actions 
No Upcoming Board Meetings
No Dividend history available
No Splits history available
No Bonus history available
No Rights history available
Quality key factors 
Valuation key factors
Technicals key factors
Shareholding Snapshot : Jun 2026
Shareholding Compare (%holding) 
Non Institution
None
Held by 0 Schemes
Held by 0 FIIs
Genesis Trade-links Private Limited (33.25%)
Jagsakti Merchandise Private Limited (11.25%)
39.45%
Quarterly Results Snapshot (Standalone) - Jun'26 - QoQ
QoQ Growth in quarter ended Jun 2026 is -15.64% vs 342.96% in Mar 2026
QoQ Growth in quarter ended Jun 2026 is -74.14% vs 2,822.22% in Mar 2026
Half Yearly Results Snapshot (Standalone) - Sep'25
Growth in half year ended Sep 2025 is -37.65% vs 132.30% in Sep 2024
Growth in half year ended Sep 2025 is 100.00% vs -80.65% in Sep 2024
Nine Monthly Results Snapshot (Standalone) - Dec'25
YoY Growth in nine months ended Dec 2025 is -5.76% vs 48.19% in Dec 2024
YoY Growth in nine months ended Dec 2025 is -4.55% vs -31.25% in Dec 2024
Annual Results Snapshot (Standalone) - Mar'26
YoY Growth in year ended Mar 2026 is 99.66% vs 10.90% in Mar 2025
YoY Growth in year ended Mar 2026 is 516.33% vs 44.12% in Mar 2025